ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,148 | -18.2% | 15,830 | -7.4% | 0.00% | 0.0% |
| Q2 2023 | $347,300 | -32.5% | 17,100 | -39.4% | 0.00% | 0.0% |
| Q1 2023 | $514,457 | +478.5% | 28,205 | +555.9% | 0.00% | – |
| Q4 2022 | $88,924 | -69.0% | 4,300 | -59.2% | 0.00% | – |
| Q2 2021 | $287,000 | -8.6% | 10,540 | -5.9% | 0.00% | -100.0% |
| Q1 2021 | $314,000 | +57.0% | 11,198 | +38.2% | 0.00% | – |
| Q2 2020 | $200,000 | -3.4% | 8,100 | -60.7% | 0.00% | – |
| Q4 2019 | $207,000 | +6.2% | 20,600 | -3.4% | 0.00% | – |
| Q3 2019 | $195,000 | +52.3% | 21,315 | +32.9% | 0.00% | – |
| Q2 2019 | $128,000 | – | 16,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
| Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
| EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
| BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
| PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
| Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
| Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
| PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
| DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |